Among these BH3 mimetics, the synthetically derived ABT-737 has been shown to induce BAX/BAK-dependent apoptosis in a variety of cancer cell lines in vitro, and to display antitumor effects as a single agent in vivo [100,101,102]. Here, BAX is linked to cancer.